Metraipolis › archive › dc_08c3b067f2eb
Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten — Europe PMC PMID:42149075
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42149075
- DOI
- 10.1016/j.jaccas.2026.108253
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T13:53:09.361Z
- SHA-256 of the archived text
2db16b1e3cac5c3eb057ab96a56fa97e1db9a4f6b71f576245ad263e0e08531b- Stable URL of this page
https://metraipolis.com/documento/dc_08c3b067f2eb
How to cite
Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten — Europe PMC PMID:42149075 — Europe PMC (en), https://europepmc.org/article/MED/42149075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08c3b067f2eb (Metraipolis archive dc_08c3b067f2eb, sha256 2db16b1e3cac5c3eb057ab96a56fa97e1db9a4f6b71f576245ad263e0e08531b)
BibTeX
@misc{dc08c3b067f2eb,
title = {Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten — Europe PMC PMID:42149075},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42149075},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08c3b067f2eb; sha256 2db16b1e3cac5c3eb057ab96a56fa97e1db9a4f6b71f576245ad263e0e08531b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42149075. Agents can read the archived copy with the MCP tool read_document.